← Back to Search

Behavioural Intervention

Brief Suicide & Trauma Therapy for Suicide Risk (BSTT Trial)

N/A
Waitlist Available
Led By Sakina Rizvi, PhD,MACP,RP
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from baseline to 12-weeks. also re-assessed at 3 months post-intervention
Awards & highlights

BSTT Trial Summary

This trial tests a combined therapy to reduce suicide risk in people with a history of childhood trauma.

Who is the study for?
This trial is for individuals who can communicate in English, have any psychiatric diagnosis, and show significant suicidal thoughts measured by a specific scale. They must be able to consent to treatment, not be in other psychotherapy programs, and have experienced childhood trauma as defined by a questionnaire.Check my eligibility
What is being tested?
The study tests Brief Suicide and Trauma Therapy (BSTT), which combines coping skills enhancement with trauma therapy aimed at reducing suicide risk due to childhood trauma. Participants will undergo this integrated intervention over a period of 12 weeks.See study design
What are the potential side effects?
While the trial focuses on psychotherapy without medication, side effects may include emotional discomfort or distress related to discussing traumatic experiences or confronting difficult emotions during therapy sessions.

BSTT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from baseline to 12-weeks. also re-assessed at 3 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and from baseline to 12-weeks. also re-assessed at 3 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in suicidal ideation using Beck Scale for Suicide Ideation
Secondary outcome measures
Change in anxiety symptoms using the Generalized Anxiety Disorder 7-item scale (GAD-7)
Change in attachment security using the Experience in Close Relationships 12-item scale (ECR)
Change in coping strategies using the Brief-Coping Orientation to Problems Experienced (Brief-COPE)
+3 more

BSTT Trial Design

1Treatment groups
Experimental Treatment
Group I: Brief Suicide and Trauma Therapy (BSTT)Experimental Treatment1 Intervention
This novel suicide intervention integrates Brief Skills for Safer Learning (B-SfSL) with trauma therapy. BSTT incorporates the guiding principles of taking a non-pathologizing approach to treatment, emphasizing safety, attending to the therapeutic relationship, empowering clients, and incorporating solution-focused concepts.

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
537 Previous Clinical Trials
447,519 Total Patients Enrolled
5 Trials studying Suicide
457 Patients Enrolled for Suicide
Sakina Rizvi, PhD,MACP,RPPrincipal InvestigatorUnity Health Toronto
1 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Suicide
20 Patients Enrolled for Suicide

Media Library

Brief Suicide and Trauma Therapy (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05613972 — N/A
Suicide Research Study Groups: Brief Suicide and Trauma Therapy (BSTT)
Suicide Clinical Trial 2023: Brief Suicide and Trauma Therapy Highlights & Side Effects. Trial Name: NCT05613972 — N/A
Brief Suicide and Trauma Therapy (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05613972 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities available to join this research endeavor?

"According to clinicaltrials.gov records, this investigation is no longer recruiting participants; the trial was initially advertised on March 1st 2023 and last updated November 4th 2022. Nonetheless, there are 1743 other trials currently in search of patients."

Answered by AI
Recent research and studies
~13 spots leftby Jun 2026